Network pharmacology research and experimental validation of Qishen decoction in the treatment of non-alcoholic fatty liver disease
Objective: To screen the main active components of Qishen decoction by network pharmacology and predict the target of its treatment for nonalcoholic fatty liver disease (NAFLD), and to verify it by experiments. Methods: The main active components of Qishen decoction and the disease target of NAFL...
Main Authors: | Shuo-Xi Li, Bing-Yu Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Editorial Board of Journal of Hainan Medical University
2020-07-01
|
Series: | Journal of Hainan Medical University |
Subjects: | |
Online Access: | http://www.hnykdxxb.com/PDF/202014/07.pdf |
Similar Items
-
16S rRNA Technology Approach to Explore Mechanism of Qishen Decoction in Improving Nonalcoholic Fatty Liver Fibrosis
by: Bing-Yu Wang, et al.
Published: (2020-01-01) -
Qishen decoction suppresses liver fibrosis by downregulating PI3K/Akt/ mTOR signal pathway
by: Shuo-Xi Li, et al.
Published: (2020-06-01) -
Effect of Qishen decoction on dedifferentiation of sinusoidal endothelial cells by autophagy
by: Xu Mao, et al.
Published: (2020-08-01) -
Hua-Zhuo-Kai-Yu decoction inhibits apoptosis in nonalcoholic fatty liver disease
by: Yu-Ting Li, et al.
Published: (2021-01-01) -
Effect of the adjuvant Baogan Jiangzhi decoction therapy on liver function and insulin sensitivity in patients with nonalcoholic fatty liver disease
by: Hong-Mei Qiang, et al.
Published: (2018-06-01)